Long-COVID and long-term cancer survivorship-Shared lessons and opportunities.
Eur J Cancer Care (Engl)
; 31(6): e13712, 2022 Nov.
Article
in English
| MEDLINE | ID: covidwho-2052399
ABSTRACT
As of 2022, close to 90 million persons in the United States, 243 million persons in Europe and 585 million worldwide have been infected with the novel SARS-CoV-2 (COVID-19) virus and survived. Estimates vary but suggest that up to 50% may experience long-term sequelae, termed 'Long-COVID'. While Long-COVID is a new condition, the phenomenon of disabling long-term effects following an illness requiring ongoing surveillance and management is not. In this commentary, we discuss how Long-COVID parallels the experiences of long-term cancer survivors, highlight shared challenges and offer opportunities to improve research and clinical care for both growing populations of patients as well as other long-term chronic, disabling conditions.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cancer Survivors
/
COVID-19
/
Neoplasms
Type of study:
Observational study
/
Prognostic study
/
Qualitative research
Topics:
Long Covid
Limits:
Humans
Country/Region as subject:
North America
/
Europa
Language:
English
Journal:
Eur J Cancer Care (Engl)
Journal subject:
Nursing
/
Neoplasms
Year:
2022
Document Type:
Article
Affiliation country:
Ecc.13712
Similar
MEDLINE
...
LILACS
LIS